Advertisement

Journal of Community Genetics

, Volume 9, Issue 3, pp 227–232 | Cite as

The effect of parental age on NF1 patients in Turkey

  • P. Sharafi
  • B. Anlar
  • S. Ersoy-Evans
  • A. Varan
  • O. F. Yılmaz
  • M. Turan
  • S. Ayter
Original Article

Abstract

Neurofibromatosis type 1 (NF1) is the most common neurogenetic disorder worldwide, and its clinical presentations are highly variable. NF1 is caused by mutations in the NF1 gene, and 50% of NF1 cases are sporadic, which occur in the absence of a family history of the disease and usually result from a new mutation in the germline of a parent. Advanced paternal age may increase the risk for germinal NF1 mutations; however, some dominant conditions, including neurofibromatosis, have shown a lesser association with paternal age, although there are conflicting reports in the literature. We investigated the effects of paternal and maternal age in 241 NF1 patients (121 sporadic and 120 familial cases) who were seen in Hacettepe hospital, a reference center for genetic diseases in Turkey. For statistical analysis, Spearman’s and Chi-square tests were used. In this study, we evaluated paternal and maternal age at birth in sporadic and familial cases of NF1. We also compared the effect of parental age on the appearance and coexistence of various NF1 symptoms. There were no significant statistical differences between paternal age and coexistence of the NF1 symptoms. However, a slightly negative correlation was observed between paternal age and the coexistence of NF1 symptoms in familial cases (p < 0.05). We did not find strong evidence for the effect of parental age on the clinical severity of NF1.

Keywords

Neurofibromatosis type 1 Advanced paternal age Advanced maternal age Spontaneous mutations 

Notes

Funding information

This study was supported by the Hacettepe University Scientific Research and Development Office (Project No. H.U.BAB. 010 T02 102).

Compliance with ethical standards

Ethical statement

This study was supported by the Hacettepe University Scientific Research and Development Office (Project No. H.U.BAB. 010 T02 102).

Conflict of interest

The authors declare that they have no conflict of interest.

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.

Informed consent was obtained from all individual participants included in the study.

References

  1. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate—a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57:289–300Google Scholar
  2. Bunin GR, Needle M, Riccardi VM (1997) Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues. Genet Epidemiol 14(5):507–516.  https://doi.org/10.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-Y CrossRefPubMedGoogle Scholar
  3. Byrne M, Agerbo E, Ewald H, Eaton WW, Mortensen PB (2003) Parental age and risk of schizophrenia: a case-control study. Arch Gen Psychiatry 60(7):673–678.  https://doi.org/10.1001/archpsyc.60.7.673 CrossRefPubMedGoogle Scholar
  4. Cantor RM, Yoon JL, Furr J, Lajonchere CM (2007) Paternal age and autism are associated in a family-based sample. Mol Psychiatry 12(5):419–421.  https://doi.org/10.1038/sj.mp.4001966 CrossRefPubMedGoogle Scholar
  5. Crow JF (2000) The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 1(1):40–47.  https://doi.org/10.1038/35049558 CrossRefPubMedGoogle Scholar
  6. Crow JF (2006) Age and sex effects on human mutation rates: an old problem with new complexities. J Radiat Res 47(Suppl B):B75–B82CrossRefPubMedGoogle Scholar
  7. Dalman C, Allebeck P (2002) Paternal age and schizophrenia: further support for an association. Am J Psychiatry 159(9):1591–1592.  https://doi.org/10.1176/appi.ajp.159.9.1591 CrossRefPubMedGoogle Scholar
  8. DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children Pediatrics 105:608–614Google Scholar
  9. Detjen AK, Tinschert S, Kaufmann D, Algermissen B, Nurnberg P, Schuelke M (2007) Analysis of mitochondrial DNA in discordant monozygotic twins with neurofibromatosis type 1. Twin Res Hum Genet 10(03):486–495.  https://doi.org/10.1375/twin.10.3.486 CrossRefPubMedGoogle Scholar
  10. Diggs-Andrews KA, Brown JA, Gianino SM, Rubin JB, Wozniak DF, Gutmann DH (2014) Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol 75(2):309–316.  https://doi.org/10.1002/ana.24093 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Dubov T, Toledano-Alhadef H, Bokstein F, Constantini S, Ben-Shachar S (2016) The effect of parental age on the presence of de novo mutations—lessons from neurofibromatosis type I. Mol Genet Genomic Med 4(4):480–486.  https://doi.org/10.1002/mgg3.222 CrossRefPubMedPubMedCentralGoogle Scholar
  12. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44(2):81–88.  https://doi.org/10.1136/jmg.2006.045906 CrossRefPubMedGoogle Scholar
  13. Fisch H, Hyun G, Golden R, Hensle TW, Olsson CA, Liberson GL (2003) The influence of paternal age on down syndrome. J Urol 169(6):2275–2278.  https://doi.org/10.1097/01.ju.0000067958.36077.d8 CrossRefPubMedGoogle Scholar
  14. Friedman JM (1981) Genetic disease in the offspring of older fathers. Obstet Gynecol 57(6):745–749PubMedGoogle Scholar
  15. Friedman JM (1999) Epidemiology of neurofibromatosis type 1. Am J Med Genet 89(1):1–6.  https://doi.org/10.1002/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8 CrossRefPubMedGoogle Scholar
  16. Glaser RL, Jabs EW (2004) Dear old dad. Sci Aging Knowledge Environ 2004:re1CrossRefPubMedGoogle Scholar
  17. Goriely A, Wilkie AO (2012) Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet 90(2):175–200.  https://doi.org/10.1016/j.ajhg.2011.12.017 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Ittel ME, Niedergang C, Munoz D, Petek F, Okazaki H, Mandel P (1975) Partial purification and characterization of an acid ribonuclease in beef brain nuclei. J Neurochem 25(2):171–176.  https://doi.org/10.1111/j.1471-4159.1975.tb12245.x CrossRefPubMedGoogle Scholar
  19. Kaplan L, Foster R, Shen Y, Parry DM, McMaster ML, O'Leary MC, Gusella JF (2010) Monozygotic twins discordant for neurofibromatosis 1. Am J Med Genet A 152A:601–606CrossRefPubMedPubMedCentralGoogle Scholar
  20. Klose A, Peters H, Hoffmeyer S, Buske A, Lüder A, Hess D, Lehmann R, Nürnberg P, Tinschert S (1999) Two independent mutations in a family with neurofibromatosis type 1 (NF1). Am J Med Genet 83(1):6–12.  https://doi.org/10.1002/(SICI)1096-8628(19990305)83:1<6::AID-AJMG3>3.0.CO;2-E CrossRefPubMedGoogle Scholar
  21. Lazaro C et al (1996) Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet 98(6):696–699CrossRefPubMedGoogle Scholar
  22. Liu Q, Zoellner N, Gutmann DH, Johnson KJ (2015) Parental age and neurofibromatosis type 1: a report from the NF1 Patient Registry Initiative. Familial Cancer 14(2):317–324.  https://doi.org/10.1007/s10689-014-9774-8 CrossRefPubMedGoogle Scholar
  23. Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33–40CrossRefPubMedGoogle Scholar
  24. Risch N, Reich EW, Wishnick MM, McCarthy JG (1987) Spontaneous mutation and parental age in humans. Am J Hum Genet 41(2):218–248PubMedPubMedCentralGoogle Scholar
  25. Shi Q, Martin RH (2000) Aneuploidy in human sperm: a review of the frequency and distribution of aneuploidy, effects of donor age and lifestyle factors. Cytogenet Cell Genet 90(3-4):219–226.  https://doi.org/10.1159/000056773 CrossRefPubMedGoogle Scholar
  26. Snajderova M, Riccardi VM, Petrak B, Zemkova D, Zapletalova J, Mardesic T, Petrakova A, Lanska V, Marikova T, Bendova S, Havlovicova M, Kaluzova M (2012) The importance of advanced parental age in the origin of neurofibromatosis type 1. Am J Med Genet A 158A(3):519–523.  https://doi.org/10.1002/ajmg.a.34413 CrossRefPubMedGoogle Scholar
  27. Szudek J, Evans DG, Friedman JM (2003) Patterns of associations of clinical features in neurofibromatosis 1 (NF1). Hum Genet 112(3):289–297.  https://doi.org/10.1007/s00439-002-0871-7 PubMedGoogle Scholar
  28. Theos A, Korf BR, American College of P, American Physiological S (2006) Pathophysiology of neurofibromatosis type 1. Ann Intern Med 144:842–849CrossRefPubMedGoogle Scholar
  29. Toriello HV, Meck JM, Professional P, Guidelines C (2008) Statement on guidance for genetic counseling in advanced paternal age. Genet Med 10(6):457–460.  https://doi.org/10.1097/GIM.0b013e318176fabb CrossRefPubMedPubMedCentralGoogle Scholar
  30. Upadhyaya M, Majounie E, Thompson P, Han S, Consoli C, Krawczak M, Cordeiro I, Cooper D (2003) Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1. Hum Genet 112(1):12–17.  https://doi.org/10.1007/s00439-002-0840-1 CrossRefPubMedGoogle Scholar
  31. Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123(1):124–133.  https://doi.org/10.1542/peds.2007-3204 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  • P. Sharafi
    • 1
  • B. Anlar
    • 2
  • S. Ersoy-Evans
    • 3
  • A. Varan
    • 4
  • O. F. Yılmaz
    • 5
  • M. Turan
    • 5
  • S. Ayter
    • 1
  1. 1.Department of Medical BiologyTOBB University of Economics and Technology, Faculty of MedicineAnkaraTurkey
  2. 2.Department of Pediatrics, Pediatric NeurologyHacettepe University, School of MedicineAnkaraTurkey
  3. 3.Department of DermatologyHacettepe University, School of MedicineAnkaraTurkey
  4. 4.Department of Pediatrics, Pediatric OncologyHacettepe University, School of MedicineAnkaraTurkey
  5. 5.Faculty of MedicineTOBB University of Economics and TechnologyAnkaraTurkey

Personalised recommendations